These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20329583)

  • 1. [The endocannabinoid system and interference with thrombogenesis].
    Kvasnicka T
    Vnitr Lek; 2010 Feb; 56(2):127-9. PubMed ID: 20329583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors.
    Baldassarri S; Bertoni A; Bagarotti A; Sarasso C; Zanfa M; Catani MV; Avigliano L; Maccarrone M; Torti M; Sinigaglia F
    J Thromb Haemost; 2008 Oct; 6(10):1772-9. PubMed ID: 18647220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids and the haematological system.
    Randall MD
    Br J Pharmacol; 2007 Nov; 152(5):671-5. PubMed ID: 17704826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of platelet activation induced by endocannabinoids in blood and plasma.
    Brantl SA; Khandoga AL; Siess W
    Platelets; 2014; 25(3):151-61. PubMed ID: 23789792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid overload.
    Lichtman AH; Blankman JL; Cravatt BF
    Mol Pharmacol; 2010 Dec; 78(6):993-5. PubMed ID: 20952498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets.
    Malorni W; Bari M; Straface E; Battista N; Matarrese P; Finazzi-Agrò A; Del Principe D; Maccarrone M
    Thromb Haemost; 2004 Nov; 92(5):1159-61. PubMed ID: 15543349
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin.
    Maccarrone M; Bari M; Del Principe D; Finazzi-Agrò A
    Thromb Haemost; 2003 Feb; 89(2):340-7. PubMed ID: 12574815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the pancreatic endocannabinoid system in glucose metabolism.
    Bermúdez-Silva FJ; Suárez Pérez J; Nadal A; Rodríguez de Fonseca F
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):87-102. PubMed ID: 19285263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid system in neurodegeneration.
    Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
    Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
    Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted lipidomics as a tool to investigate endocannabinoid function.
    Astarita G; Geaga J; Ahmed F; Piomelli D
    Int Rev Neurobiol; 2009; 85():35-55. PubMed ID: 19607960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesia through endogenous cannabinoids.
    Secko D
    CMAJ; 2005 Aug; 173(4):357. PubMed ID: 16103504
    [No Abstract]   [Full Text] [Related]  

  • 15. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
    Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
    J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human platelets by 2-arachidonoylglycerol: role of PKC in NO/cGMP pathway modulation.
    Signorello MG; Giacobbe E; Segantin A; Avigliano L; Sinigaglia F; Maccarrone M; Leoncini G
    Curr Neurovasc Res; 2011 Aug; 8(3):200-9. PubMed ID: 21675954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoids control the induction of cerebellar LTD.
    Safo PK; Regehr WG
    Neuron; 2005 Nov; 48(4):647-59. PubMed ID: 16301180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid 2-arachidonoyl-glycerol activates human neutrophils: critical role of its hydrolysis and de novo leukotriene B4 biosynthesis.
    Chouinard F; Lefebvre JS; Navarro P; Bouchard L; Ferland C; Lalancette-Hébert M; Marsolais D; Laviolette M; Flamand N
    J Immunol; 2011 Mar; 186(5):3188-96. PubMed ID: 21278347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.
    Mukhopadhyay S; Tulis DA
    Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):311-8. PubMed ID: 17979695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.